For example, ERBB2 itself is not a known DCM gene in the Mendelian sense, but it is the target of the monoclonal antibody and breast cancer drug, trastuzumab (Herceptin), the current standard of care for HER2+ breast cancer patients [8]. The gene discussed is ERBB2; the disease is breast cancer.